Clinical Trials List
2018-09-26 - 2022-05-18
Phase III
Recruiting6
ICD-10C67.9
Malignant neoplasm of bladder, unspecified
ICD-10C67
Malignant neoplasm of bladder
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- Yen-Hwa Chang Division of Urology
- Tzeon-jye Chiou Division of Hematology & Oncology
- 陳威任 無
- Mu-Hsin Chang Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Jiun-I Lai 無
- Tzu-chun Wei Division of Urology
- Tzu-Ping Lin Division of Urology
- Yi-Hsiu Huang Division of Urology
- 沈書慧 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Yi-Huei Chang Division of Urology
- Po-Jen Hsiao Division of Urology
- Hsi-Chin Wu Division of Urology
- Wei-Ching Lin Division of Radiology
- Po-Fan Hsieh Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- 陳冠亨 Division of Urology
- Chi-Rei Yang Division of Urology
- Chi-Ping Huang Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- Han Chang Division of Others -
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shian-Shiang Wang Division of Urology
- 王樹吉 Division of Urology
- Chuan-Shu Chen Division of Urology
- 洪晟鈞 Division of Urology
- Cheng-Che Chen Division of Urology
- 裘坤元 Division of Urology
- Chia-Yen Lin Division of Urology
- 熊小澐 Division of Urology
- Cheng-Kuang Yang Division of Urology
- 盧嘉文 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Urology
- Jiann-Hui Ou Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- 劉忠一 Division of Hematology & Oncology
- 張境夫 無
- See-Tong Pang Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Recruiting
Audit
None
Co-Principal Investigator
- - - Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO
- PO-MING CHOW Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- - - Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- YEN-HENG LIN
- Yeong-Shiau Pu Division of Urology
- YU-CHUAN LU Division of Urology
- 王中傑
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
1735 participants
